Two years after its $26-million purchase of Genomic Solutions, Harvard Bioscience said last week that it can align the unit profitably with its operations.

“We believe we have taken the necessary steps to return Genomic Solutions to profitability on its current run rate of revenues,” Chane Graziano, the Holliston, Mass.-based company’s CEO, said in a conference call with analysts last week. “The worst is behind us.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.